Effect of NMN (Nicotinamide Mononucleotide) on Polycystic Ovary Syndrome

Clinical trial NCT05305677 · COMPLETED

Trial details

NCT number: NCT05305677
Sponsor: Peking University Third Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Polycystic Ovary Syndrome

Start date: 2022-06-01
Primary completion: 2023-12-31
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.